Appendix B - Appendix B to Subpart G of Part 1—List of Modified Nucleotides
Source: World Intellectual Property Organization (WIPO) Handbook on Industrial Property Information and Documentation, Standard ST.25: Standard for the Presentation of Nucleotide and Amino Acid Sequence Listings in Patent Applications (2009).
| Symbol | Meaning | ac4c | 4-acetylcytidine. | chm5u | 5-(carboxyhydroxymethyl)uridine. | cm | 2′-O-methylcytidine. | cmnm5s2u | 5-carboxymethylaminomethyl-2-thiouridine. | cmnm5u | 5-carboxymethylaminomethyluridine. | d | dihydrouridine. | fm | 2′-O-methylpseudouridine. | gal q | beta, D-galactosylqueuosine. | gm | 2′-O-methylguanosine. | i | inosine. | i6a | N6-isopentenyladenosine. | m1a | 1-methyladenosine. | m1f | 1-methylpseudouridine. | m1g | 1-methylguanosine. | m1i | 1-methylinosine. | m22g | 2,2-dimethylguanosine. | m2a | 2-methyladenosine. | m2g | 2-methylguanosine. | m3c | 3-methylcytidine. | m5c | 5-methylcytidine. | m6a | N6-methyladenosine. | m7g | 7-methylguanosine. | mam5u | 5-methylaminomethyluridine. | mam5s2u | 5-methoxyaminomethyl-2-thiouridine. | man q | beta, D-mannosylqueuosine. | mcm5s2u | 5-methoxycarbonylmethyl-2-thiouridine. | mcm5u | 5-methoxycarbonylmethyluridine. | mo5u | 5-methoxyuridine. | ms2i6a | 2-methylthio-N6-isopentenyladenosine. | ms2t6a | N-((9-beta-D-ribofuranosyl-2-methylthiopurine-6-yl)carbamoyl)threonine. | mt6a | N-((9-beta-D-ribofuranosylpurine-6-yl)N-methylcarbamoyl)threonine. | mv | uridine-5-oxyacetic acid-methylester. | o5u | uridine-5-oxyacetic acid. | osyw | wybutoxosine. | p | pseudouridine. | q | queuosine. | s2c | 2-thiocytidine. | s2t | 5-methyl-2-thiouridine. | s2u | 2-thiouridine. | s4u | 4-thiouridine. | t | 5-methyluridine. | t6a | N-((9-beta-D-ribofuranosylpurine-6-yl)-carbamoyl)threonine. | tm | 2′-O-methyl-5-methyluridine. | um | 2′-O-methyluridine. | yw | wybutosine. | x | 3-(3-amino-3-carboxy-propyl)uridine, (acp3)u. |
|---|